Specialty Chemicals Market Is Projected To Growing At A CAGR of 5.6% During Forecast Period 2014-2025

Global Specialty Chemicals Market is expected to reach USD 1.79 trillion by 2025, according to a new report by Grand View Research, Inc. Growing popularity of high-value chemicals that play a crucial role in the development of novel products is a major driving factor for the industry.

Specialized & advanced features of these compounds lends them a significant advantage in comparison with commodity products, since the former are formulated on the basis of unique performance characteristics for specific applications in the construction, automotive, electronics, agriculture and other sectors.

International chemical authorities are widely advocating the passage of free trade agreements such as Transatlantic Trade Investment Partnership (TTIP) between the U.S. and Europe which is expected to foster manufacturing & trade of these products over the near future. Recovery in housing starts and rebounding growth of the automotive sector in North America is also a key trend impacting market dynamics.

Construction chemicals accounted for 12% of the volume share in 2016 and are expected to emerge as the fastest growing segment with over 5.7% CAGR from 2017 to 2025. The steady demand for residential projects & public infrastructure in emerging economies remains a key driving factor for compounds utilized in the production, maintenance & repair of building components.

Full Research Report On Global Specialty Chemicals Market Analysis: http://www.grandviewresearch.com/industry-analysis/specialty-chemicals-market

Further key findings from the report suggest:

• The global specialty chemicals market exceeded 260 million tons in 2016 and is expected to grow at a CAGR of 5.1% from 2017 to 2025
• Coatings, adhesives, sealants & elastomers (CASE) is growing at a rapid CAGR of over 5% owing to high demand for specialty adhesives, paints, coatings and other materials in high-performance applications
• Electronic chemicals are expected to remain an important & fast-growing segment owing to integration of miniaturized electronics in automobiles, development of solar-powered devices and rapid digitalization across emerging economies
• Automotive applications are expected to increase at 6.0% CAGR from 2017 to 2025. Automation in assembly and other OEM processes are expected to contribute to an increase in production levels, which is turn is likely to foster higher chemicals industry revenue
• Asia Pacific is anticipated to increase at the highest pace owing to rapidly expanding automotive and electronics sectors, along with a steady rise in industrial output in recent years.
• Low cost labor and vast material resources are also contributing to growth in Asia Pacific, as foreign players make advances & investments in emerging nations.
• Key industry participants such as BASF, Henkel, The Dow Chemical Company, ExxonMobil, Huntsman Corporation, AkzoNobel, Evonik Industries, PPG Industries, Avery Dennison and others are actively participating in new product launches, R&D, strategic expansions and M&A to expand their reach and improve product offering to emerging customer segments

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers

Grand View Research has segmented the Global Specialty Chemicals Market on the basis of product, application, and region:

Specialty Chemicals Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• CASE
• Agrochemicals
• Electronic Chemicals
• Construction Chemicals
• Specialty Polymers & Resins
• Others

Specialty Chemicals Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Automotive
• Construction
• Agriculture
• Industrial Manufacturing
• Consumer Goods
• Others

Specialty Chemicals Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Middle East & Africa
• Saudi Arabia

View Press Release Of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-specialty-chemicals-market                           

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Agrochemicals Market Is Estimated To Growing At A CAGR Of 4.1% During Forecast Period 2014-2025

Global Agrochemicals Market is expected to reach USD 308.92 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for crop protection chemicals, such as fungicides, herbicides, and insecticides, is expected to be the biggest driver of the agrochemicals industry over the forecast period.  

Shrinking arable land due to rapid industrialization and population explosion has resulted in increased use of agrochemicals, such as fertilizers and plant growth regulators, further triggering the market growth. The growing demand for crops as animal fodder and fiber in the textile industry has also provided the necessary boost to the agrochemicals industry.

Fertilizers dominated the agrochemicals market in 2016. Nitrogenous and phosphate fertilizers were most widely used due to their easy availability and low prices. However, the new trend of organic farming, which involves complete elimination of chemical-based fertilizers, has increased the demand for biofertilizers.

The demand for agrochemicals is expected to be the highest in Asia Pacific. The region is known for its agro-based countries such as India, Sri Lanka, and China, which are majorly dependent on agriculture and related industries for economic growth.

Full Research Report on Global Agrochemicals Market Analysis: http://www.grandviewresearch.com/industry-analysis/agrochemicals-market

Further key findings from the report suggest:

• The global agrochemicals market, in terms of value, was USD 215.18 billion in 2016 and is projected to reach USD 308.92 billion by 2025, growing at a CAGR of 4.1% from 2017 to 2025
• Fertilizers, which accounted for 58.8% of the market in 2016, in terms of revenue, are expected to witness growth on account of increasing pressure on agricultural land to increase yield in a short time span
• Crop protection chemicals, in terms of revenue, are expected to grow at a CAGR of 5.5% from 2017 to 2025 due to rising occurrences of pest and rodent attacks damaging crops
• The market for agrochemicals in cereals & grains was valued at USD 80.01 billion in 2016. The application segment is expected to grow owing to an increase in the demand for whole grain products.
• Oilseeds & pulses, which are considered to have high protein content, are projected to grow at the highest CAGR of 4.9%, in terms of value, from 2017 to 2025
• The market in Asia Pacific is expected to witness the highest growth over the forecast period due to the growing agro-based industries including sugar, textiles, vegetable oil manufacturing, and animal husbandry
• Bayer CropScience, Agrium, and Yara International were some of the key manufacturers in 2016 with distribution facilities spread across all regions

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers

Grand View Research has segmented the Global Agrochemicals Market on the basis of product, application, and region:

Agrochemicals Product Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)

• Fertilizers
• Crop Protection Chemicals
• Plant Growth Regulators
• Others

Agrochemicals Application Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)

• Cereals & Grains
• Oilseeds & Pulses
• Fruits & Vegetables
• Others

Agrochemicals Regional Outlook (Volume, Kilotons; Revenue, USD Billion; 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• Spain
• Asia Pacific
• China
• India
• Central & South America
• Brazil
• Middle East & Africa 

View Blog On this research report by Grand View Research: http://www.grandviewresearch.com/blog/agrochemicals-market-size-share                          

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Blood Collection Market Is Estimated TO Growing At A CAGR 6.1% During Forecast Period 2014-2025

Global Blood Collection Market is expected to reach a value of USD 13.3 billion by 2025, according to a new report by Grand View Research, Inc. The increasing incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period. According to the Centers for Disease Control and Prevention (CDC), in 2013, around 19.3 million people visited the physician’s clinic for infectious and parasitic diseases testing in the U.S. Moreover, according to International Diabetes Federation, 415 million people suffered from diabetes in 2014 and this number is expected to rise up to 642 million by 2040. Thus, the increasing incidence of accidents and trauma cases is another factor that drives the demand for blood collection products for therapeutic application.

The increasing number of surgical procedures is an additional key factor contributing to the growth. The escalating number of accidental injury cases is expected to propel the demand for target market products for therapeutics application. According to the CDC, in the U.S, around 31.0 million patients visited emergency centers for unintentional injuries in 2014. Thus, the demand for blood collection products such as bags, needles, and syringes is growing at a high rate, which is expected to boost the growth during the forecast period.

Full Research Report on Global Blood Collection Market Analysis:
http://www.grandviewresearch.com/industry-analysis/blood-collection-market

Further Key Findings from the Study Suggest:

• The needles and syringes segment was the largest grossing segment of the blood collection market in 2015 owing to the growing application of these devices in diagnosis and treatment of      various disorders like diabetes and blood-related diseases
• The diagnostics application segment held the largest revenue share in 2015, owing to rising geriatric population and escalating prevalence of infectious & non-communicable diseases
• In 2015, the hospitals segment accounted for the largest share in the market due to an upsurge in the incidence of trauma & accidental cases along with growing number of surgical procedures
• North America held the largest share of the blood collection market in the year 2015. This region is estimated to uphold its dominance during the study period
• The presence of a highly developed healthcare infrastructure and advanced blood collection products is anticipated to boost the growth in North America during the forecast period
• Some of the key companies include Abbott Laboratories, NIPRO Medical Corp., Becton, Dickinson and Company, Terumo Corp., Medtronic, Qiagen, and FL MEDICAL s.r.l.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Blood Collection Market on the basis of product, application, end-use, and region:

Blood Collection Product Outlook (Revenue, USD Million; 2014 - 2025)

• Needles and Syringes
• EDTA Tubes
• Heparin Tubes
• Serum-Separating Tubes
• Plasma-Separating Tubes
• Blood Bags
• Others

Blood Collection Application Outlook (Revenue, USD Million; 2014 - 2025)

• Diagnostics
• Treatment

Blood Collection End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Hospitals
• Diagnostics centers
• Blood banks
• Others

Blood Collection Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Blog On this research report by Grand View Research: http://www.grandviewresearch.com/blog/blood-collection-market-size-share                               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Building Integrated Photovoltaics (BIPV) Market Study Report Covers Revenue forecast, company share, competitive landscape, growth factors and trends 2013-2024

Global BIPV And BIOPV Market size is expected to reach USD 31.14 billion by 2024, according to a new report by Grand View Research, Inc. Rising adoption of energy generation by renewable sources without comprising on the aesthetic appeal of buildings is expected to drive growth over the forecast period.

Increasing demand for integrated installations is expected to be driven by the growing disposable income of the consumers. In addition, rising concerns regarding averse environmental impact due to the use of non-renewable energy sources are likely to account for the growth of the industry over the next eight years.

The industry has witnessed increased adoption of the environment-friendly energy sources by the multi-national corporations to limit the carbon footprints. In addition, growing subsidies and tax reductions offered by the national governments is expected to bolster the demand for the product.

The demand for the product has stemmed from the increased adoption of the integrated roofs, walls and windows owing to superior aesthetic properties. In addition, the industry has witnessed increased efforts towards the research & development activities leading to the development of magnetic nanoparticles incorporated solar cells, leading to an enhanced efficiency of the overall installation.

Full Research Report on Global Building Integrated Photovoltaics (BIPV) Market Analysis:
http://www.grandviewresearch.com/industry-analysis/building-integrated-photovoltaics-bipv-market

Further key findings from the report suggest

• Building integrated roofs accounted for over 61% of the overall revenue due to superior efficiency of the roof-integrated systems. In addition, improved aesthetic appeal coupled with the ease of the integration of the solar energy harnessing systems for rooftop installations.
• Thin-film building integrated photovoltaics is expected to witness highest CAGR of over 20% from 2016 to 2024 due to superior integration with the building envelopes in comparison to the crystalline silicon.
• The thin film is expected to grow owing to significant technology advancements leading to improved performance efficiency as well as superior aesthetic appeal as compared to its counterparts.
• The market in Asia Pacific is expected to account for USD 7.48 Billion by 2024 due to increasing demand for the technology from the rapidly developing building and construction industry in the region.
• The companies in the market are involved in significant research & development activities to produce advanced products, in a bid to increase the market share. Heliatek GmbH introduced the organic building integrated photovoltaic cells, with high band gap resulting in superior efficiency.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/renewable-energy

Grand View Research has segmented the Global BIPV Market on the basis of technology, application, end-use and region:

• Technology Outlook (Revenue, USD Million, 2013 - 2024)
• Crystalline Silicon (C-Si)
• Thin Film
• Others
• Application Outlook (Revenue, USD Million, 2013 - 2024)
• Roofs
• Walls
• Glass
• Facade
• Others
• End-Use Outlook (Revenue, USD Million, 2013 - 2024)
• Residential
• Commercial
• Industrial
• Regional Outlook (Revenue, USD Million, 2013 - 2024)
• North America

§  U.S.

§  Canada

·         Europe

§  Germany

§  UK

·         Asia Pacific

§      China

§      India

·         Latin America

·         Middle East & Africa

View Press Release Of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-building-integrated-photovoltaics-bipv-market                              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Platelet Rich Plasma Market Is Expected To Grow At A CAGR Of 13.3% Over The Forecast Period 2014-2025

Global Platelet Rich Plasma (PRP) Market is expected to reach USD 647.1 million by 2025, according to a new report by Grand View Research, Inc. Growing prevalence of orthopedic diseases and increasing application of PRP in cosmetic surgery is propelling the demand for the market. Platelet-rich plasma has become one of the cutting-edge technologies for a number of medical applications including orthopedics, general surgery, cosmetic surgery, cardiovascular surgery, wound healing, and others.

Platelet rich plasma treatments aid in soft tissue healing and reduce the risk of post and preoperative bleeding. As a result, it is considered as one of the most significant treatment methods for the management of several chronic diseases. The most enticing fact about this treatment is that the procedure helps in regeneration of ligament and tendon fibers, which can possibly obviate the need for surgery and result in enormous growth of the PRP market during the forecast period.

Full Research Report On Global Platelet Rich Plasma (PRP) Market Analysis:
http://www.grandviewresearch.com/industry-analysis/platelet-rich-plasma-prp-market

Further key findings from the study suggest:

• The market study suggests that pure PRP dominated the overall market in 2016 owing to its greater capability and suitability for bone regeneration and improved patient response due to less inflammation
• However, leukocyte-rich PRP is expected to witness highest growth rate due to the presence of inductive properties that help in stimulation of healing processes. Treatment with leukocyte-rich PRP is anticipated to be one of the most favorable methods in the future for the treatment of soft tissue defects
• Amongst the application segments, orthopedics occupied the largest share in 2016 as PRP injections aid in rapid augmentation of soft tissue healing process. Few orthopedic complications that have been treated successfully with PRP techniques include knee osteoarthritis, Achilles tendinopathy, lateral epicondylitis, rotator cuff tears, and ulnar collateral ligament
• The cosmetic surgery and dermatology application segment is expected to grow at the highest growth rate during the forecast period as PRP injections trigger the production of new cells and promote collagen formation, which naturally tightens and smoothens the skin
• North America dominated the regional segment with the largest revenue share in 2016, due to increasing orthopedic disorders & sport injuries and greater developments in the field of plasma therapy
• Asia Pacific is expected to witness significant growth during the forecast period, primarily due to growing awareness regarding platelet rich plasma treatment, rising demand for cosmetic procedures, and booming medical tourism industry in the region
• Some of the major companies operating in this market are T-Biotechnology (T-LAB); Arthrex, Inc.; Terumo BCT, Inc.; EmCyte Corporation; DePuy Synthes; Zimmer Biomet; Stryker; Glofinn Oy; DR. PRP AMERICA, LLC; and others.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Platelet Rich Plasma (PRP) Market on the basis of product, application, and region:

Platelet Rich Plasma Product Outlook (Revenue, USD Million, 2014 - 2025)

• Pure PRP
• Leukocyte-Rich PRP
• Leukocyte-Rich Fibrin

Platelet Rich Plasma Application Outlook (Revenue, USD Million, 2014 - 2025)

• Orthopedics
• Cosmetic Surgery & Dermatology
• Ophthalmic Surgery
• Neurosurgery
• General surgery
• Others

Platelet Rich Plasma Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-platelet-rich-plasma-prp-market                             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bisphenol A (BPA) Market Demand Is Estimated To Growing At A CAGR Of 4.7% From 2014 To 2020

Global Market For Bisphenol A (BPA) is expected to reach USD 20.03 billion by 2020, according to a new study by Grand View Research, Inc. BPA is largely used for the production of polycarbonates and growing demand of polycarbonates in consumer goods and medical devices is expected to be a key driver for the market. In addition, the growing construction industry and growing BPA demand in automobile industry are expected to further augment market growth. However, health hazards associated with the use of BPA resulting in regulatory pressure is expected to be a key challenge for the industry over the next six years.

Polycarbonate was the largest application segment accounting for 5,083.5 kilo tons of BPA demand in 2013; followed by epoxy resin applications, with market volume estimated at 1,414.7 kilo tons in 2013. Superior performance of epoxy resins, in terms of thermal stability, corrosion protection and mechanical strength for industrial applications is expected to reflect in BPA demand; as a key monomer for these resins.

Full Research Report on Global Bisphenol A (BPA) Market Analysis:
http://www.grandviewresearch.com/industry-analysis/bisphenol-a-bpa-market

Further key findings from the study suggest:

• The global demand for BPA was 7,000.9 Kilo tons in 2013 and is expected to reach 9,618.7 Kilo tons by 2020, growing at a CAGR of 4.7% from 2014 to 2020.

• Asia Pacific was largest regional market for BPA with 54% of market share and revenue of USD 7.00 billion in 2013. This was owing to the presence of large number of end-user industries coupled with low labor, raw material and operating cost in the region. In addition, many conglomerates have shifted their base to Asia Pacific on account of the aforementioned reasons.

• North America and Europe are expected to witness below average growth, at an estimated CAGR of 4.5% and 4.3% respectively from 2014 to 2020. Governments of Canada and European Union have banned the use of polycarbonate’s derived products resulting in decreased demand for BPA.

• The global BPA market is somewhat fragmented with top four companies accounting for less than 45% of the market in 2013. Key companies in the market include Bayer Material Sciences, Dow Chemicals, SABIC Innovative Plastics and Mitsui Chemicals among others.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

For the purpose of this study, Grand View Research has segmented the Global BPA Market on the basis of application, product and region:

    • BPA Applications Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
            • Polycarbonates
            • Epoxy resins
            • Others (Unsaturated polyester resins, flame retardants, polyacrylate, polysulfone resins, polyetherimide, etc.)
    • BPA Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
            • North America
            • Europe
            • Rest of Asia
            • RoW

View Press Release Of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bisphenol-a-bpa-market                            

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Blood Screening Market Is Projected To Grow At A CAGR Of 10.2% Over The Forecast Period 2013-2024

Global Blood Screening Market is expected to reach a value of USD 3.9 billion by 2024, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing screening of donor and continuous technological advancements by the market players. 

Demand for blood screening tests are increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). Result of all these assays must be negative for blood donation.

Technological developments in the market increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Full Research Report on Global Blood Screening Market Analysis:
http://www.grandviewresearch.com/industry-analysis/blood-screening-market

Further Key Findings from the Study Suggest:

• Nucleic acid amplification test or nucleic acid test (NAT) is expected to be the fastest growing segment during the forecast period. It comprises transcription mediated amplification (TMA) tests and polymerase chain reaction. Increasing demand of NAT over ELISA test due to high sensitivity and specificity for viral nucleic acid is contributing to the fastest growth during the forecast period.
• In 2015, reagent dominated the product segment. Introduction of new assays for the detection of various diseases is expected to enable the segment to gain the maximum share of market in the coming years. For instance, in January 2015 the FDA approved Roche’s blood screening assay COBAS TaqScreen MPX Test for the detection and identification of HCV, HIV, and HBV. 
• In 2015, regionally North America dominated with a revenue share of more than 40%. Government initiatives, presence of major players, and more patient affordability are the major factors that contributed toward its dominance.
• In August 2016, the FDA recommended the testing of all the donated blood in the U.S. and its territories for Zika virus in order to prevent transmission of this virus through the blood supply.
• Asia Pacific is expected to be the fastest growing region due to increasing investment of industry players, government initiatives, and rising awareness about transmission of diseases during its transfusion.
• The Red Cross in Japan entered into a contract with Grifols for nucleic acid testing (NAT) for a blood donation camp in Japan in 2014. This agreement is anticipated to propel the NAT market during the forecast period. However, low donation as compared to requirement and high cost of kits and instruments are likely to restrain the growth in low-income countries during the forecast period.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics  

Grand View Research has segmented the Global Blood Screening Market by technology, product and region:

Blood Screening Market Technology Outlook (Market Revenue in USD Million, 2013 - 2024)

• Nucleic Acid Amplification Test (NAT)
• ELISA
• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
• Next-Generation Sequencing (NGS)
• Western Blotting

Blood Screening Market Product Outlook (Market Revenue in USD Million, 2013 - 2024) 

• Reagent
• Instrument

Blood Screening Market Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa
• South Africa

View Press Release Of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-blood-screening-market                           

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com